Suppression of endothelin-converting enzyme-1 by sucralfate, a factor in gastric mucosal resistance to indomethacin injury in rats

Author： Slomiany B. L.   Slomiany A.  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.8, Iss.2, 2000-06, pp. : 207-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increases of vascular endothelin-converting enzyme activity and endothelin-1 level on atherosclerotic lesions in hyperlipidemic rabbits

By Mitani H.   Takimoto M.   Bandoh T.   Kimura M.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite

The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1537-1552

Informa Healthcare

Access to resources Recommend Favorite

Isoforms of endothelin-converting enzyme: why and where?

By Turner A.J.   Barnes K.   Schweizer A.   Valdenaire O.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 12, 1998-12 ,pp. : 483-486

Elsevier

Access to resources Recommend Favorite

The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity

By Deschepper C.F.   Houweling A.D.   Picard S.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

Expression of human endothelin-converting enzyme isoforms: role of angiotensin II

By Schubert A.   Morawietz H.   Goettsch W.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 6, 2008-06 ,pp. : 299-309

NRC Research Press

Access to resources Recommend Favorite